Based on previous studies that proved that the silencing of CDK6 in ALL‐Ph+ was more effective than its inhibition by palbociclib, revealing the importance of the kinase‐independent and dependent mechanisms of CDK6, several CDK6‐selective PROTACs were designed.148, 153. This evidence concerns the gene CDK6 and acute lymphoblastic leukemia.